BAHRAM VALAMEHR

Person

SAN DIEGO, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Enhanced immune effector cells and use thereof
- Patent number 12,173,274
- Issue date Dec 24, 2024
- Fate Therapeutics, Inc.
- Bahram Valamehr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chimeric antigen receptor for tumor targeting
- Patent number 12,122,846
- Issue date Oct 22, 2024
- Fate Therapeutics, Inc.
- Bahram Valamehr
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Composition and methods for inducing myeloid suppressive cells and...
- Patent number 11,851,677
- Issue date Dec 26, 2023
- Fate Therapeutics, Inc.
- Philippe A. Parone
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for inducing hematopoietic cell differenti...
- Patent number 11,634,688
- Issue date Apr 25, 2023
- Fate Therapeutics, Inc.
- Bahram Valamehr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Platform for the induction and maintenance of ground state pluripot...
- Patent number 11,441,126
- Issue date Sep 13, 2022
- Fate Therapeutics, Inc.
- Bahram Valamehr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for immune cell modulation in adoptive imm...
- Patent number 11,413,309
- Issue date Aug 16, 2022
- Fate Therapeutics, Inc.
- Jonathan Rosen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Enhanced immune effector cells and use thereof
- Patent number 11,365,394
- Issue date Jun 21, 2022
- Fate Therapeutics, Inc.
- Bahram Valamehr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Genomic engineering of pluripotent cells
- Patent number 11,352,607
- Issue date Jun 7, 2022
- Fate Therapeutics, Inc.
- Bahram Valamehr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Reprogramming methods and cell culture platforms
- Patent number 11,268,069
- Issue date Mar 8, 2022
- Fate Therapeutics, Inc.
- Bahram Valamehr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for inducing hematopoietic cell differenti...
- Patent number 11,162,075
- Issue date Nov 2, 2021
- Fate Therapeutics, Inc.
- Bahram Valamehr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for inducing hematopoietic cell differenti...
- Patent number 11,162,076
- Issue date Nov 2, 2021
- Fate Therapeutics, Inc.
- Bahram Valamehr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for immune cell modulation in adoptive imm...
- Patent number 11,096,964
- Issue date Aug 24, 2021
- Fate Therapeutics, Inc.
- Jonathan Rosen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genomic engineering of pluripotent cells
- Patent number 11,072,781
- Issue date Jul 27, 2021
- Fate Therapeutics, Inc.
- Bahram Valamehr
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Minimal volume reprogramming of mononuclear cells
- Patent number 10,954,529
- Issue date Mar 23, 2021
- Fate Therapeutics, Inc.
- Peter Flynn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for inducing hematopoietic cell differenti...
- Patent number 10,947,505
- Issue date Mar 16, 2021
- Fate Therapeutics, Inc.
- Bahram Valamehr
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Enhanced immune effector cells and use thereof
- Patent number 10,927,346
- Issue date Feb 23, 2021
- Fate Therapeutics, Inc.
- Bahram Valamehr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for inducing hematopoietic cell differenti...
- Patent number 10,858,628
- Issue date Dec 8, 2020
- Fate Therapeutics, Inc.
- Bahram Valamehr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cell culture platform for single cell sorting and enhanced reprogra...
- Patent number 10,844,356
- Issue date Nov 24, 2020
- Fate Therapeutics, Inc.
- Bahram Valamehr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for inducing hematopoietic cell differenti...
- Patent number 10,626,372
- Issue date Apr 21, 2020
- Fate Therapeutics, Inc.
- Bahram Valamehr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Genomic engineering of pluripotent cells
- Patent number 10,287,606
- Issue date May 14, 2019
- Fate Therapeutics, Inc.
- Bahram Valamehr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Minimal volume reprogramming of mononuclear cells
- Patent number 10,023,879
- Issue date Jul 17, 2018
- Fate Therapeutics, Inc.
- Peter Flynn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cell culture platform for single cell sorting and enhanced reprogra...
- Patent number 9,732,319
- Issue date Aug 15, 2017
- Fate Therapeutics, Inc.
- Bahram Valamehr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
OFF-THE-SHELF IPSC-DERIVED CAR-NK CELL AS MONOTHERAPY AND IN COMBIN...
- Publication number 20240382523
- Publication date Nov 21, 2024
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROTECTED EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CE...
- Publication number 20240307540
- Publication date Sep 19, 2024
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEE...
- Publication number 20240226293
- Publication date Jul 11, 2024
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITION AND METHODS FOR INDUCING MYELOID SUPPRESSIVE CELLS AND...
- Publication number 20240158747
- Publication date May 16, 2024
- FATE THERAPEUTICS, INC.
- Philippe A. Parone
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEE...
- Publication number 20240131156
- Publication date Apr 25, 2024
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEE...
- Publication number 20240115602
- Publication date Apr 11, 2024
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OFF-THE-SHELF iPSC-DERIVED NK CELL THERAPY FOR HEMATOLOGICAL CANCER...
- Publication number 20240100092
- Publication date Mar 28, 2024
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED iPSC AND ARMED IMMUNE EFFECTOR CELLS
- Publication number 20240033355
- Publication date Feb 1, 2024
- FATE THERAPEUTICS, INC.
- Dan LU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMPROVED REPROGRAMMING, MAINTENANCE AND PRESERVATION FOR INDUCED PL...
- Publication number 20240034999
- Publication date Feb 1, 2024
- FATE THERAPEUTICS, INC.
- Yi-Shin LAI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTOR FOR TUMOR TARGETING
- Publication number 20240002532
- Publication date Jan 4, 2024
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGINEERED IPSC AND IMMUNE EFFECTOR CELLS FOR HETEROGENOUS TUMOR CO...
- Publication number 20230405121
- Publication date Dec 21, 2023
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED IPSC AND PERSISTENT IMMUNE EFFECTOR CELLS
- Publication number 20230390337
- Publication date Dec 7, 2023
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTIPLEXED ENGINEERED IPSCS AND IMMUNE EFFECTOR CELLS TARGETING SO...
- Publication number 20230381235
- Publication date Nov 30, 2023
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELLS HAVING SOLID TUMOR TARGETING BACKBONE AND USE THEREOF
- Publication number 20230357716
- Publication date Nov 9, 2023
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINING IPSC DERIVED EFFECTOR CELL TYPES FOR IMMUNOTHERAPY USE
- Publication number 20230235287
- Publication date Jul 27, 2023
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTI...
- Publication number 20230212518
- Publication date Jul 6, 2023
- FATE THERAPEUTICS, INC.
- Bahram Valamehr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENHANCEMENT OF iPSC-DERIVED EFFECTOR IMMUNE CELL USING SMALL COMPOUNDS
- Publication number 20230016034
- Publication date Jan 19, 2023
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMM...
- Publication number 20220401487
- Publication date Dec 22, 2022
- FATE THERAPEUTICS, INC.
- Jonathan Rosen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTI-TARGETING EFFECTOR CELLS AND USE THEREOF
- Publication number 20220378831
- Publication date Dec 1, 2022
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PLATFORM FOR THE INDUCTION & MAINTENANCE OF GROUND STATE PLURIPOTENCY
- Publication number 20220325249
- Publication date Oct 13, 2022
- FATE THERAPEUTICS, INC.
- Bahram Valamehr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF
- Publication number 20220275333
- Publication date Sep 1, 2022
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
REPROGRAMMING METHODS AND CELL CULTURE PLATFORMS
- Publication number 20220228125
- Publication date Jul 21, 2022
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD3 RECONSTITUTION IN ENGINEERED iPSC AND IMMUNE EFFECTOR CELLS
- Publication number 20220184142
- Publication date Jun 16, 2022
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOTHERAPIES USING ENHANCED iPSC DERIVED EFFECTOR CELLS
- Publication number 20220127328
- Publication date Apr 28, 2022
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMM...
- Publication number 20210393695
- Publication date Dec 23, 2021
- FATE THERAPEUTICS, INC.
- Jonathan Rosen
- G01 - MEASURING TESTING
Information Patent Application
GENOMIC ENGINEERING OF PLURIPOTENT CELLS
- Publication number 20210324340
- Publication date Oct 21, 2021
- FATE THERAPEUTICS, INC.
- Bahram Valamehr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTI...
- Publication number 20210230549
- Publication date Jul 29, 2021
- FATE THERAPEUTICS, INC.
- Bahram Valamehr
- G01 - MEASURING TESTING
Information Patent Application
METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTI...
- Publication number 20210222126
- Publication date Jul 22, 2021
- FATE THERAPEUTICS, INC.
- Bahram Valamehr
- G01 - MEASURING TESTING
Information Patent Application
MINIMAL VOLUME REPROGRAMMING OF MONONUCLEAR CELLS
- Publication number 20210198687
- Publication date Jul 1, 2021
- FATE THERAPEUTICS, INC.
- PETER FLYNN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENHANCED IMMUNE EFFECTOR CELLS AND USE THEREOF
- Publication number 20210180017
- Publication date Jun 17, 2021
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

BAHRAM VALAMEHR

Person

Patents Grantslast 30 patents

Enhanced immune effector cells and use thereof

Chimeric antigen receptor for tumor targeting

Composition and methods for inducing myeloid suppressive cells and...

Methods and compositions for inducing hematopoietic cell differenti...

Platform for the induction and maintenance of ground state pluripot...

Compositions and methods for immune cell modulation in adoptive imm...

Enhanced immune effector cells and use thereof

Genomic engineering of pluripotent cells

Reprogramming methods and cell culture platforms

Methods and compositions for inducing hematopoietic cell differenti...

Methods and compositions for inducing hematopoietic cell differenti...

Compositions and methods for immune cell modulation in adoptive imm...

Genomic engineering of pluripotent cells

Minimal volume reprogramming of mononuclear cells

Methods and compositions for inducing hematopoietic cell differenti...

Enhanced immune effector cells and use thereof

Methods and compositions for inducing hematopoietic cell differenti...

Cell culture platform for single cell sorting and enhanced reprogra...

Methods and compositions for inducing hematopoietic cell differenti...

Genomic engineering of pluripotent cells

Minimal volume reprogramming of mononuclear cells

Cell culture platform for single cell sorting and enhanced reprogra...

Patents Applicationslast 30 patents

OFF-THE-SHELF IPSC-DERIVED CAR-NK CELL AS MONOTHERAPY AND IN COMBIN...

PROTECTED EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CE...

ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEE...

COMPOSITION AND METHODS FOR INDUCING MYELOID SUPPRESSIVE CELLS AND...

ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEE...

ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEE...

OFF-THE-SHELF iPSC-DERIVED NK CELL THERAPY FOR HEMATOLOGICAL CANCER...

ENGINEERED iPSC AND ARMED IMMUNE EFFECTOR CELLS

IMPROVED REPROGRAMMING, MAINTENANCE AND PRESERVATION FOR INDUCED PL...

CHIMERIC ANTIGEN RECEPTOR FOR TUMOR TARGETING

ENGINEERED IPSC AND IMMUNE EFFECTOR CELLS FOR HETEROGENOUS TUMOR CO...

ENGINEERED IPSC AND PERSISTENT IMMUNE EFFECTOR CELLS

MULTIPLEXED ENGINEERED IPSCS AND IMMUNE EFFECTOR CELLS TARGETING SO...

CELLS HAVING SOLID TUMOR TARGETING BACKBONE AND USE THEREOF

COMBINING IPSC DERIVED EFFECTOR CELL TYPES FOR IMMUNOTHERAPY USE

METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTI...

ENHANCEMENT OF iPSC-DERIVED EFFECTOR IMMUNE CELL USING SMALL COMPOUNDS

COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMM...

MULTI-TARGETING EFFECTOR CELLS AND USE THEREOF

PLATFORM FOR THE INDUCTION & MAINTENANCE OF GROUND STATE PLURIPOTENCY

IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF

REPROGRAMMING METHODS AND CELL CULTURE PLATFORMS

CD3 RECONSTITUTION IN ENGINEERED iPSC AND IMMUNE EFFECTOR CELLS

IMMUNOTHERAPIES USING ENHANCED iPSC DERIVED EFFECTOR CELLS

COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMM...

GENOMIC ENGINEERING OF PLURIPOTENT CELLS

METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTI...

METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTI...

MINIMAL VOLUME REPROGRAMMING OF MONONUCLEAR CELLS

ENHANCED IMMUNE EFFECTOR CELLS AND USE THEREOF